Dihomo-gamma-linolenic acid
| Dihomo-gamma linolenic acid | |
|---|---|
| 200px | |
| Other names | cis,cis,cis-8,11,14-Eicosatrienoic acid DGLA |
| Identifiers | |
| CAS number | |
| PubChem | |
| SMILES | CCCCCC=CCC=CCC=CCCCCCCC(=O)O (canonical) CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(=O)O (isomeric) |
| Properties | |
| Molecular formula | C20H34O2 |
| Molar mass | 306.483 g/mol |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) Infobox disclaimer and references | |
Dihomo-gamma-linolenic acid (DGLA) is a 20-carbon ω-6 fatty acid. In physiological literature, it is given the name 20:3(n-6). Chemically, DGLA is a carboxylic acid with a 20-carbon chain and three cis double bonds; the first double bond is located at the sixth carbon from the omega end. DGLA is the elongation product of γ-linolenic acid [18:3(n-6)].
Biological effects
The eicosanoid metabolites of DGLA are:
- Series-1 thromboxanes (thromboxanes with 1 double-bond), via the COX-1 and COX-2 pathways.
- Series-1 prostanoids, via the COX-1 and COX-2 pathways.[1]
- A 15-hydroxyl derivative that blocks the transformation of arachidonic acid to leukotrienes.[2]
All of these effects are anti-inflammatory. This is in marked contrast with the analogous metabolites of arachidonic acid (AA) which are the series-2 thromboxanes and prostanoids and the series-4 leukotrienes. In addition to yielding anti-inflammatory eicosanoids, DGLA competes with AA for COX and lipoxygenase, inhibiting the production of AA's eicosanoids.
Taken orally in a small study, DGLA produced antithrombotic effects.[3] Supplementing dietary GLA increases serum DGLA without increasing serum AA.[4]
References
- ↑ Fan, Yang-Yi and Robert S. Chapkin (9 September 1998). "Importance of Dietary gamma -Linolenic Acid in Human Health and Nutrition". Journal of Nutrition 128 (9): 1411-1414. Retrieved on 2007-10-16.
- ↑ Belch, Jill JF and Alexander Hill (January 2000). Evening primrose oil and borage oil in rheumatologic conditions. Retrieved on February 12, 2006. PubMed cite
- ↑ Kernoff PB, Willis AL, Stone KJ, Davies JA, McNicol GP (1977). "Antithrombotic potential of dihomo-gamma-linolenic acid in man". British medical journal 2 (6100): 1441–4. PMID 338112.
- ↑ Johnson MM, Swan DD, Surette ME, et al (1997). "Dietary supplementation with gamma-linolenic acid alters fatty acid content and eicosanoid production in healthy humans". J. Nutr. 127 (8): 1435–44. PMID 9237935.
 | This biochemistry article is a stub. You can help WikiDoc by expanding it. |
Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs
Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link HereThere is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
